Detection of modified DNA nucleotides by postlabeling procedures

Toxicology Methods

Volumn 8, Issue 3, 1998, Pages 175-205

  Izzotti, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

32P postlabeling; DNA adducts; Genotoxic damage

Indexed keywords

AFLATOXIN; ALKYLATING AGENT; DNA; NUCLEOTIDE DERIVATIVE;

DEPOLYMERIZATION; DNA ADDUCT; DNA DAMAGE; DNA DETERMINATION; DNA STRUCTURE; GENOTOXICITY; HUMAN; IONIZING RADIATION; PRIORITY JOURNAL; REVIEW;

EID: 0031715497     PISSN: 10517235     EISSN: None     Source Type: Journal    
DOI: 10.1080/105172398242880     Document Type: Review

References (57)

1. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis. 1982;3:1081-1092.
2. 32P-postlabeling test for DNA damage. Proc Natl Acad Sci USA. 1981;78:6126-6129.
3. Randerath E, Yu CT, Randerath K. Base analysis of ribopolynucleotides by chemical tritium labeling: a model study with model nucleosides and purified tRNA species. Anal Biochem. 1972;48:172-198.
4. Randerath K, Randerath E. Ion-exchange thin-layer chromatography, XV: preparation, properties and applications of paper-like PEI-cellulose sheets. J Chromatogr. 1966;22:110-117.
5. 32P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res. 1985;45:5656-5662.
6. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis. 1986;7:1543-1551.
7. 32P-postlabelling assay for aromatic DNA adducts in white blood cells of iron foundry workers. Mutat Res. 1989;224:485-492.
8. 32P-postlabelling. In: Phillips DH, Castegnaro M, Bartsch H, eds. Postlabelling Methods for Detection of DNA Adducts. Lyon, France; 1993:35-49.
9. 32P-postlabeling. Carcinogenesis. 1995;16:613-617.
10. Cesarone CF, Bolognesi C, Santi L. Improved microfluorimetric DNA determination in biological material using 33258 Hoechst. Anal Biochem. 1979;100:188-197.
11. 32P-postlabeling of thymidine glycol in γ-irradiated DNA. Carcinogenesis. 1989;10:43-47.
12. Phillips DH, Hewer A, Grower PL. Aromatic DNA adducts in human bone marrow and peripheral blood leukocytes. Carcinogenesis. 1986;7:2071-2075.
13. 32P-postlabeling assay. Carcinogenesis. 1992;13:1053-1074.
14. 32P-postlabeling assay for DNA adducts induced by cis-diaminedichloroplatinum(II). Cancer Lett. 1994;83:129-137.
15. 32P-postlabeling of 7-methyl-guanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dicarbazine and procarbazine: human data and method development for 7-alkylguanines. Carcinogenesis. 1991;12:1423-1431.
16. 32P-postlabeling of adducts as labeled nucleoside biphosphates, dinucleotides and nucleoside monophosphates. Carcinogenesis. 1990;11:1349-1357.
17. 32P-postlabeling. Carcinogenesis. 1995;16:113-118.
18. Bykov VJ, Hemminki K. UV-induced photoproducts in human skin explants analysed by TLC and HPLC-radioactivity detection. Carcinogenesis. 1995;16:3015-3019.
19. 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5′-monophosphates. Carcinogenesis. 1989;10:1231-1239.
20. 32P-postlabeling of DNA adducts induced by a Fenton-type oxygen radical-generating system. Carcinogenesis. 1992;13:1127-1135.
21. 32P-postlabeling. Free Rad Res. 1998;28:165-178.
22. 32P labeling and thin layer chromatography. In: Friedberg EC, Hanawalt PC, eds. DNA Repair. New York: Dekker; 1988: 399-418.
23. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis. 1988;9:1687-1693.
24. Izzotti A, D'Agostini F, Bagnasco M, et al. Chemoprevention of carcinogen-DNA adducts chronic degenerative diseases. Cancer Res. 1994;54(suppl):1994s-1998s.
25. 32P postlabeling. Cancer Res. 1993;53:1522-1528.
26. Talaska G, Al-Jaburi AZSS, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA. 1991;88:5350-5354.
27. Izzotti A, Camoirano A, D'Agostini F, et al. Biomarker alterations produced in rat lung by intratracheal instillations of air particulate extracts and chemoprevention with oral N-acetycysteine. Cancer Res. 1996;56:1533-1538.
28. Randerath E, Watson WP, Zhou D-G, Chang J, Randerath K. Intensification and depletion of specific bulky DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA). Mutat Res. 1995;341:265-279.
29. Gupta KP, van Golen KL, Randerath E, Randerath K. Age-dependent covalent DNA alterations (I-compounds) in rat liver mitochondrial DNA. Mutat Res. 1990;237:17-27.
30. 32P-postlabeling assay for aromatic carcinogen-DNA adducts. Carcinogenesis. 1991;12:1745-1748.
31. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vineze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer. 1990;46:569-575.
32. Izzotti A, De Flora S, Petrilli GL, et al. Cancer biomarkers in human atherosclerotic lesions, I: detection of DNA adducts. Cancer Epidemiol Biomarkers Prev. 1995;4:105-110.
33. Gaubatz JW. Postlabeling analysis of indigenous aromatic DNA adducts in mouse myocardium during ageing. Arch Gerontol Geriatr. 1989;8:47-54.
34. De Flora S, Izzotti A, Randerath K, et al. DNA adducts and chronic degenerative diseases: pathogenetic relevance and implications in preventive medicine. Mutat Res. 1996;366:197-238.
35. Degan P, Bonassi S, De Caterina M, et al. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of active oxygen species in Fanconi's anaemia families. Carcinogenesis. 1995;16:735-741.
36. 32P-postlabeling. Anal Biochem. 1992;201:127-133.
37. 32P-postlabeling assay and the basal level in rat tissues. Carcinogenesis. 1996;17:917-924.
38. 32P postlabeling and electrochemical detection. Carcinogenesis. 1997;18:2367-2371.
39. 32P-postlabeling analysis. Carcinogenesis. 1988;9:1055-1060.
40. 32P-postlabeling measurement of adenine N-1-oxide in cellular DNA exposed to hydrogen peroxide. Chem Res Toxicol. 1990;3:102-110.
41. 32P-postlabeling of ELISA. Mutat Res. 1993;292:113-122.
42. Kriek E, Den Engelse L, Scherer E, Westra JG. Formation of DNA modifications by chemical carcinogens. Identification, localization and quantification. Biochim Biophys Acta. 1984;738:181-201.
43. Holtz O, Krause T, Rudiger HW. Differences in DNA adduct formation between monocytes and lymphocytes after in vivo incubation with benzo[α]pyrene. Carcinogenesis. 1991;12:2181-2183.
44. 35S-phosphorothioate labeling and HPLC. Carcinogenesis. 1991;12:885-893.
45. Kelman DJ, Lilga KT, Sharma M. Synthesis and application of fluorescent labeled nucleotides to assay DNA damage. Chem Biol Interact. 1988;66:85-100.
46. Sharma M, Box HC, Kelman DJ. Fluorescence postlabeling assay of cis-thymidine glycol monophosphate in X-irradiated calf-thymus DNA. Chem Biol Interact. 1990;74:107-117.
47. Sharma M, Box HC, Paul CR. Detection and quantitation of 8-hydroxyguanosine-5′-monophosphate in X-irradiated calf-thymus DNA by fluorescence postlabeling. Biochem Biophys Res Commun. 1990;167:419-424.
48. 32P-postlabeling: comparison with cigarette smoke-associated DNA adduct profiles in vivo. Mutat Res. 1992;268:139-153.
49. 32P-postlabeling analysis of small aromatic and of bulky non-aromatic DNA adducts. In: Phillips DH, Castegnaro M, Bartsch H, eds. Postlabeling Methods for Detection of DNA Adduct. Lyon, France: IARC; 1993:25-34.
50. Randerath K, Lu L-JW, Li D. A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating liver. Carcinogenesis. 1988;9:1843-1848.
51. 1 treatment. Cancer Lett. 1989;45:7-12.
52. 32P-postlabeling and multifraction contact-transfer thin-layer chromatography. Fundam Appl Toxicol. 1994;23: 308-312.
53. Gupta RC, Sopori ML, Gairola CG. Formation of cigarette smoke-induced DNA adducts in the rat lung and nasal mucosa. Cancer Res. 1989;49:1916-1920.
54. 32P-postlabeled DNA adducts. J Chromatogr. 1993;612:295-301.
55. 32P-HPLC suitable for characterization of DNA adducts formed in vitro by polycyclic aromatic hydrocarbons and derivatives. Carcinogenesis. 1995;16:1-9.
56. 32P-HPLC. Carcinogenesis. 1996;17:61-66.
57. 32P-postlabeling assay. Carcinogenesis. 1992;13:1475-1479.